Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2021 08:30 ET | Source: Daxor Corporation

Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference

NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will...
January 08, 2021 08:30 ET | Source: Daxor Corporation

Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned...
October 06, 2020 08:30 ET | Source: Daxor Corporation

New Research Shows Daxor’s BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Presented at the Heart Failure Society of America Meeting 2020

NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
October 02, 2020 08:30 ET | Source: Daxor Corporation

New Data Released from the Mayo Clinic Utilizing Daxor’s BVA-100® Test Highlights Value of Daxor’s Diagnostic at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020

NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
September 15, 2020 08:30 ET | Source: Daxor Corporation

Daxor to Present at the Inaugural Sepsis Alliance Summit

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
August 31, 2020 08:30 ET | Source: Daxor Corporation

Daxor Corporation to Present at the LD 500 Virtual Investor Conference

NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
April 23, 2020 08:30 ET | Source: Daxor Corporation

Daxor Awarded $1.1 Million Contract from United States Department of Defense (DOD) for Rapid Portable Blood Volume Analyzer

New York, April 23, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
March 20, 2020 08:00 ET | Source: Daxor Corporation

Daxor Corporation’s BVA-100® Test Used to Guide Treatment In COVID-19 Patient

New Clinical Protocol for Volume-Guided Therapy Helps Combat Coronavirus NEW YORK, March 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative...
March 09, 2020 08:30 ET | Source: Daxor Corporation

Daxor Corporation Contracted to Adapt Its Blood Volume Analyzer Technology for U.S. Air Force Needs

NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
March 06, 2020 08:00 ET | Source: Daxor Corporation

Daxor Corporation Announces Closing of $2.0 Million Registered Direct Offering Priced At-The-Market

NEW YORK, March 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology...

Next Page keyboard_arrow_right